AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (June 1, 2006). doi:10.1152/ajpgi.00055.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/G556    most recent
00055.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raman, K. G
Right arrow Articles by Fink, M. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raman, K. G
Right arrow Articles by Fink, M. P
Submitted on February 2, 2006
Accepted on May 1, 2006

The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock

Kathleen G Raman1, Penny L Sappington2, Runkuan Yang2, Ryan M Levy1, Jose M Prince1, Shiguang Liu2, Simon K. Watkins3, Ann Marie Schmidt4, Timothy R Billiar1, and Mitchell P Fink5*

1 Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
2 Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
3 Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
4 Department of Surgery, College of Physicians and Surgeons of Columbia University, New York, New York, United States
5 Departments of Surgery and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States

* To whom correspondence should be addressed. E-mail: finkmp{at}upmc.edu.

The receptor for advanced glycation end-products (RAGE) has been implicated in the pathogenesis of numerous conditions associated with excessive inflammation. To determine whether RAGE-dependent signaling is important in the development of intestinal barrier dysfunction after hemorrhagic shock and resuscitation (HS/R), C57Bl/6, rage-/- or congenic rage +/+ mice were subjected to HS/R (mean arterial pressure of 25 mm Hg for 3 h) or a sham procedure. Twenty-four h later, bacterial translocation (BT) to mesenteric lymph nodes and ileal mucosal permeability to FITC-labeled dextran were assessed. Additionally, samples of ileum were obtained for immunofluorescence microscopy and plasma was collected for measuring IL-6 and IL-10 levels. HS/R in C57Bl/6 mice was associated with increased BT, ileal mucosal hyperpermeability and high circulating levels of IL-6. All of these effects were prevented when C57Bl/6 mice were treated with recombinant human sRAGE (the extracellular ligand-binding domain of RAGE). HS/R induced BT, ileal mucosal hyperpermeability and high plasma IL-6 levels in rage +/+ but not rage-/- mice. Circulating IL-10 levels were higher in rage-/- as compared to rage -/- mice. These results suggest that activation of RAGE-dependent signaling is a key factor leading to gut mucosal barrier dysfunction after HS/R.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.